GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Lotus Bio-Technology Development Corp (OTCPK:LBTD) » Definitions » Interest Expense

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Interest Expense : $0.00 Mil (TTM As of Dec. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Lotus Bio-Technology Development Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Lotus Bio-Technology Development's interest expense for the three months ended in Dec. 2017 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2017 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Lotus Bio-Technology Development's Operating Income for the three months ended in Dec. 2017 was $ -0.00 Mil. Lotus Bio-Technology Development's Interest Expense for the three months ended in Dec. 2017 was $ 0.00 Mil. Lotus Bio-Technology Development has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Lotus Bio-Technology Development Interest Expense Historical Data

The historical data trend for Lotus Bio-Technology Development's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Bio-Technology Development Interest Expense Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Interest Expense
Get a 7-Day Free Trial - - - - -

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lotus Bio-Technology Development Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development  (OTCPK:LBTD) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lotus Bio-Technology Development's Interest Expense for the three months ended in Dec. 2017 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2017 was $-0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2017 was $0.00 Mil.

Lotus Bio-Technology Development's Interest Coverage for the quarter that ended in Dec. 2017 is calculated as

Lotus Bio-Technology Development had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Lotus Bio-Technology Development Corp (OTCPK:LBTD) » Definitions » Interest Expense
Comparable Companies
BOM:538858 NSE:BOHRA FSE:4995 BOM:530433 TSX:KRN BOM:524687 SNES ROCO:8496 WAR:BIK BOM:540071 TSXV:FGR CVAT BOM:503776 BOM:537292 BOM:531862 BOM:590128 BOM:539470 SGX:1H2 NSE:AGROPHOS BOM:524808
Traded in Other Exchanges
N/A
Address
108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Website
http://www.starflick.com
Lotus Bio-Technology Development Corp is a biotechnology development company. It focuses on specializing in the refining of organic materials and the production of natural consumer-related products. It is exploring opportunities in the organic growth and farming sector in China and provides local customers the real organic food products with affordable prices and guarantees that all of them will be produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones, or other dangerous chemicals. All the operation is primarily functioned through the region of China.
Executives
Zoltan Nagy other: FX President/CEO 1361 PELTIER DR., POINT ROBERTS WA 98281